Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

《Clinical And Translational Medicine》是一本由JOHN WILEY & SONS LTD出版商出版的专业医学期刊，该刊创刊于2012年，刊期1 issue/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 2区，小类学科：医学：研究与实验 2区；肿瘤学 3区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖医学：研究与实验等领域，旨在及时、准确、全面地报道国内外医学：研究与实验工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为8.554，平均审稿速度4 Weeks。